Latest news
Ceruvia Raises $8 Million to Complete Integrated Phase 1/2 Trial of Proprietary Non-Hallucinogenic LSD Analog for Cluster Headache - PR NewswirePR Newswire · Mon, 03 Aug 2026 14:00:00 GMTHealthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT